BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 25156887)

  • 1. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A; Kung J
    Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
    Wang MT; Lee WJ; Huang TY; Chu CL; Hsieh CH
    Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment of hyperthyroidism during lactation: review of the literature and novel data.
    Karras S; Tzotzas T; Kaltsas T; Krassas GE
    Pediatr Endocrinol Rev; 2010 Sep; 8(1):25-33. PubMed ID: 21037541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
    Hackmon R; Blichowski M; Koren G
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicological considerations for antithyroid drugs in children.
    Karras S; Tzotzas T; Krassas GE
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):399-410. PubMed ID: 21323607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic treatment of hyperthyroidism during pregnancy.
    Cassina M; Donà M; Di Gianantonio E; Clementi M
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):612-9. PubMed ID: 22511519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hyperthyroidism in pregnancy and birth defects.
    Clementi M; Di Gianantonio E; Cassina M; Leoncini E; Botto LD; Mastroiacovo P;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E337-41. PubMed ID: 20668039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with carbimazole of a hyperthyroid pregnancy with hepatic impairment after propylthiouracil administration: a case report.
    Kontoleon P; Ilias I; Koutras DA; Kontogiannis D; Papapetrou PD
    Clin Exp Obstet Gynecol; 2002; 29(4):304-5. PubMed ID: 12635752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thyrostatic treatment and its adverse effects].
    Dokupilová A; Payer J
    Vnitr Lek; 2013 Nov; 59(11):989-95. PubMed ID: 24279443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of antithyroid drugs in pregnancy: update and therapy implications.
    Francis T; Francis N; Lazarus JH; Okosieme OE
    Expert Opin Drug Saf; 2020 May; 19(5):565-576. PubMed ID: 32223355
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
    Chen CH; Xirasagar S; Lin CC; Wang LH; Kou YR; Lin HC
    BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodies.
    Stege R
    Acta Chir Scand Suppl; 1980; 501():1-130. PubMed ID: 6163270
    [No Abstract]   [Full Text] [Related]  

  • 14. The propylthiouracil dilemma.
    Glinoer D; Cooper DS
    Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):402-7. PubMed ID: 22820213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propylthiouracil versus methimazole during pregnancy: an evolving tale of difficult choices.
    Rivkees SA
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4332-5. PubMed ID: 24194618
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
    Yang J; Li LF; Xu Q; Zhang J; Weng WW; Zhu YJ; Dong MJ
    Thyroid; 2015 Mar; 25(3):278-83. PubMed ID: 25384184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity from antithyroid drugs.
    Vitug AC; Goldman JM
    Horm Res; 1985; 21(4):229-34. PubMed ID: 4007783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis.
    Agrawal M; Lewis S; Premawardhana L; Dayan CM; Taylor PN; Okosieme OE
    Clin Endocrinol (Oxf); 2022 Jun; 96(6):857-868. PubMed ID: 34845757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis.
    Song R; Lin H; Chen Y; Zhang X; Feng W
    PLoS One; 2017; 12(7):e0180108. PubMed ID: 28671971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital anomalies in children exposed to antithyroid drugs in-utero: a meta-analysis of cohort studies.
    Li H; Zheng J; Luo J; Zeng R; Feng N; Zhu N; Feng Q
    PLoS One; 2015; 10(5):e0126610. PubMed ID: 25974033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.